The latest price target for Humana (NYSE:HUM) was reported by Cantor Fitzgerald on September 20, 2024. The analyst firm set a price target for $395.00 expecting HUM to rise to within 12 months (a possible 27.25% upside). 52 analyst firms have reported ratings in the last year.

The latest analyst rating for Humana (NYSE:HUM) was provided by Cantor Fitzgerald, and Humana reiterated their neutral rating.

The last upgrade for Humana Inc happened on December 12, 2023 when Argus Research raised their price target to $550. Argus Research previously had a hold for Humana Inc.

The last downgrade for Humana Inc happened on April 2, 2024 when B of A Securities changed their price target from $470 to $342 for Humana Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Humana, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Humana was filed on September 20, 2024 so you should expect the next rating to be made available sometime around September 20, 2025.

While ratings are subjective and will change, the latest Humana (HUM) rating was a reiterated with a price target of $395.00 to $395.00. The current price Humana (HUM) is trading at is $310.41, which is out of the analyst’s predicted range.